Drug Approval | February 25, 2023
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Subscribe To Our Newsletter & Stay Updated
